interleukin-16 receptor

• インターロイキン16受容体、インターロイキン16レセプター

関

IL-16 receptor

WordNet

1. a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
2. any of several lymphokines that promote macrophages and killer T cells and B cells and other components of the immune system

PrepTutorEJDIC

1. =sense organ / 受信装置

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 成人における再生不良性貧血の治療treatment of aplastic anemia in adults [show details]
  …with daclizumab, a humanized monoclonal antibody directed at the interleukin 2 (IL-2) receptor . There were six responses among the 16 evaluable patients (38 percent), two of whom reverted to completely …
• 2. 進行黒色腫に対するインターロイキン2および実験的免疫学的アプローチinterleukin 2 and experimental immunotherapy approaches for advanced melanoma [show details]
  …chemotherapy (biochemotherapy) , and various toxicity reduction agents, such as (TNFR) and interleukin-1 receptor (IL-1R) antagonists. Although activity was seen with all of these approaches, none of these … approach had a clinically significant benefit in a minority of patients . The objective response rate was 16 percent, with a median duration of nine months (range 4 to 106+ months), and 59 percent of complete …
• 3. β-2アドレナリン受容体機能不全および喘息の多型性beta 2 adrenergic receptor dysfunction and polymorphism in asthma [show details]
  … such as interleukin 1-beta ; Beta-2 receptor number is increased by in vitro exposure to glucocorticoids ; The possibility that medication-induced changes in beta receptor density or… these and other beta receptor polymorphisms in the genesis and course of asthma. The Arg/Arg polymorphism at position 16 of the beta-2 adrenergic receptor may be associated with…
• 4. 腫瘍壊死因子受容体-1関連周期性発熱症候群（TRAPS）tumor necrosis factor receptor 1 associated periodic syndrome traps [show details]
  … treatment of patients with TRAPS using the interleukin (IL) 6 receptor antagonist tocilizumab .… baseline flare by day 15 and no additional flares by week 16) was seen with canakinumab than control (45 versus 6 percent,…
• 5. 肝移植後の急性細胞性拒絶反応の治療treatment of acute cellular rejection of the liver allograft [show details]
  …rejection develop glucocorticoid-resistant rejection . Agents including thymoglobulin, anti-interleukin receptor antibodies, mycophenolate mofetil (MMF), sirolimus, and tacrolimus have been used as rescue …

English Journal

• Interleukin-16 inhibits sodium channel function and GluA1 phosphorylation via CD4- and CD9-independent mechanisms to reduce hippocampal neuronal excitability and synaptic activity.

• Hridi SU, Franssen AJPM, Jiang HR, Bushell TJ.
• Molecular and cellular neurosciences. 2019 03;95()71-78.
• Interleukin 16 (IL-16) is a cytokine that is primarily associated with CD4 T cell function, but also exists as a multi-domain PDZ protein expressed within cerebellar and hippocampal neurons. We have previously shown that lymphocyte-derived IL-16 is neuroprotective against excitotoxicity, but evidenc
• PMID 30738184

• Association of Methylenetetrahydrofolate Reductase, Vitamin D Receptor, and Interleukin-16 Gene Polymorphisms With Renal Cell Carcinoma Risk.

• Zhou T, Li H, Xie WJ, Zhong Z, Zhong H, Lin ZJ.
• Technology in cancer research & treatment. 2019 01;18()1533033819859413.
• In this meta-analysis, we investigated the association of methylenetetrahydrofolate reductase, vitamin D receptor, and interleukin-16 gene polymorphisms with the risk of renal cell carcinoma. We searched the PubMed and Cochrane Library databases up to July 1, 2017, and included 12 eligible case-cont
• PMID 31242814

• Ablation of the CD9 receptor in human lung cancer cells using CRISPR/Cas alters migration to chemoattractants including IL-16.

• Blake DJ, Martiszus JD, Lone TH, Fenster SD.
• Cytokine. 2018 Nov;111()567-570.
• CD9, a member of the tetraspanin superfamily, has been implicated in regulating various physiological processes, including cell motility, adhesion, apoptosis and metastasis. Recently, interleukin-16 (IL-16), a pro-inflammatory cytokine released by normal airway and alveolar epithelial cells, has bee
• PMID 29884309

Japanese Journal

• Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-<i>κ</i>B Pathway

• Hashikata Takehiro,Ako Junya,Yamaoka-Tojo Minako,Namba Sayaka,Kitasato Lisa,Kameda Ryo,Murakami Masami,Niwano Hiroe,Shimohama Takao,Tojo Taiki
• International Heart Journal 56(5), 544-550, 2015
• … Factor Xa (FXa)-dependent protease-activated receptor (PAR)-1 and PAR-2 have been reported as important targets in proinflammatory and fibroproliferative diseases. … In mouse cytokine array measuring 40 cytokines, the productions of interleukin-16, TIMP-1, and tumor necrosis factor-<i>α</i> …
• NAID 130005102116

Related Links

• Interleukin-16. - National Center for Biotechnology Information

1. J Leukoc Biol. 2000 Jun;67(6):757-66. Interleukin-16. Cruikshank WW(1), Kornfeld H, Center DM. Author information: (1)Pulmonary Center, Boston University School of Medicine, Massachusetts 02118, USA ...

• Interleukin-16: Multiple Roles in Human Pathology | Boston ...

Structure and Function History Interleukin 16 (IL-16), formerly known as lymphocyte chemoattractant factor or LCF, is a pro-inflammatory cytokine that is chemotactic for CD4 + T lymphocytes, monocytes, and eosinophils. In addition ...

---

★リンクテーブル★

リンク元	「インターロイキン16受容体」「IL-16 receptor」「インターロイキン16レセプター」
関連記事	「interleukin」「interleukins」

「インターロイキン16受容体」

　　[★]

英

interleukin-16 receptor、IL-16 receptor

関

インターロイキン16レセプター、IL-16受容体、IL-16レセプター

「IL-16 receptor」

　　[★]

• インターロイキン16受容体、IL-16受容体、IL-16レセプター

関

interleukin-16 receptor

「インターロイキン16レセプター」

　　[★]

英

interleukin-16 receptor

関

インターロイキン16受容体

「interleukin」

　　[★] インターロイキン IL 　

「interleukins」

　　[★] インターロイキン IL